MBX Biosciences, Inc. (MBX)

CIK 1776111 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for MBX Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
Aug 27, 20268-K0001193125-26-369674
Aug 17, 20261440001959173-26-006112
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003482
Aug 10, 2026SCHEDULE 13D/A0000947871-26-000776
Aug 10, 2026SCHEDULE 13D/A0001231919-26-000851
Aug 6, 202610-Q0001193125-26-336849
Aug 6, 20268-K0001193125-26-336841
Aug 5, 202640001193125-26-335373
Aug 4, 20261440001959173-26-005628
Aug 4, 202640001193125-26-331642
Aug 4, 202640001193125-26-331639
Aug 4, 20261440001959173-26-005629
Jul 29, 2026SCHEDULE 13G0002012383-26-002818
Jul 13, 20268-K0001193125-26-302098
Jul 8, 2026SCHEDULE 13G/A0000902219-26-000214
Jul 8, 2026SCHEDULE 13G/A0000315066-26-001474
Jun 24, 2026SCHEDULE 13G0001104659-26-077301
Jun 12, 20268-K0001193125-26-268477
Jun 10, 20261440001959173-26-004511
Jun 9, 20261440001959173-26-004487
Jun 5, 202640001193125-26-258432
Jun 5, 202640001193125-26-258429
Jun 5, 202640001193125-26-259236
Jun 5, 202640001193125-26-258422
Jun 5, 202640001193125-26-258435